Tricia Gooljarsingh
Tricia Gooljarsingh is currently Vice President Medical Affairs, The Janssen Pharmaceutical Companies of Johnson and Johnson. Previous positions include VP and Head of Global Medical Affairs at Momenta Pharmaceuticals, and Senior Director of Medical and Scientific Affairs at Ironwood Pharmaceuticals based in Cambridge, MA where she oversaw the therapeutic area leads responsible for scientific communications including congress activity, publication planning, data generation, medical information, medical affairs strategy, advocacy, promotional review and commercial support.
Prior to that Tricia led the medical communications groups at Baxter, Baxalta and then Shire pharmaceuticals spanning seven therapeutic areas from 2013-2017. Before joining Baxter Tricia held roles of increasing responsibilities at GSK, Wyeth and Bayer pharmaceuticals.
Tricia received her PhD in Biochemistry from Pennsylvania State University under the direction of Dr. Stephen Benkovic and has published several papers in the field of oncology basic research.
Scott Alexander
Scott Alexander, MBBS is a Medical Science Liaison with Lundbeck Canada and is based out of Vancouver, BC.
Dr. Alexander has worked for just under five years in the life sciences industry and Medical Affairs area. Prior to joining Lundbeck Canada in 2020, he was with Novo Nordisk as a diabetes and obesity MSL for one year and the Medical Director at Veritas Pharma establishing their strategic product development from phases I-III for pain models using cannabinoid medicines.
Dr. Alexander earned his medical degree from the University of Queensland in Brisbane, Australia. He accepted an internship at Rockhampton Base Hospital before moving back to Canada to begin his family.
Scott has a Bachelor and Master of Science in Biomedical Physiology and Kinesiology from Simon Fraser University. He lives in Vancouver with his wife and children and enjoys playing hockey and getting outside as much as the Vancouver weather permits.
